RT Journal Article SR Electronic T1 Beware That COVID-19 Would Be Worse in Winter: A Study of a Global Panel of 1236 Regions JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.07.29.20164152 DO 10.1101/2020.07.29.20164152 A1 Zhang, Chen A1 Liao, Hua A1 Strobl, Eric A1 Li, Hui A1 Li, Ru A1 Jensen, Steen Solvang A1 Zhang, Ying YR 2020 UL http://medrxiv.org/content/early/2020/09/13/2020.07.29.20164152.abstract AB It is believe that weather conditions such as temperature and humidity have effects on COVID-19 transmission. However, these effects are not clear due to the limited observations and difficulties in separating impacts of social distancing. COVID-19 data and social-economic features of 1236 regions in the world (1112 regions at the provincial level and 124 countries with small land area) were collected. A Large-scale satellite data was combined with these data with a regression analysis model to explore effects of temperature and relative humidity on COVID-19 spreading, as well as the possible transmission risk by seasonal cycles. The result show that temperature and relative humidity are shown to be negatively correlated with COVID-19 transmission throughout the world. Further, the effect of temperature and humidity is almost linear based on our samples, with uncertainty surrounding any non-linear effects. Government intervention (e.g. lockdown policies) and lower population movement contributed to the decrease the new daily case ratio. The conclusions withstand several robustness checks, such as observation scales and maximum/minimum temperature. Weather conditions are not the decisive factor in COVID-19 transmission, in that government intervention as well as public awareness, could contribute to the mitigation of the spreading of the virus. As temperature drops in winter, the transmission possibly speeds up again. It deserves a dynamic government policy to mitigate COVID-19 transmission in winter.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNational Natural Science Foundation of China (71521002, 71925008).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval required. The study does not use data on individual human subjects. This study uses aggregate data at subnational level.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this study are obtained from publicly available online sources, and the sources are listed in the paper.